For every treatment team and researcher to have instant access to expert opinions and the latest evidence-based information in MDS, to aid in treatment decisions and improve the lives of patients with MDS globally.
Enhance the collective knowledge base in MDS through global multichannel dissemination of the most up-to-date evidence-based information in MDS, to help inform on disease management and treatment strategies.
The MDS Hub was founded in partnership with the European LeukemiaNet (ELN). The ELN is a publicly-funded network of excellence, where clinicians and scientists improve therapy options for patients with leukemia worldwide. Together, they look to define strategies to improve leukemia characterization, its common diagnostic procedures and therapeutic standards, as well as to facilitate clinical and fundamental research. This approach results in the advancement of leukemia research and it supports equal access for all patients to the best possible care.